Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MILEX NORGE AS
AS
Active
Org 979399030
Skjelavikvegen 73, 5515 Haugesund
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 1997
2 employees
www.milex.no
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 4M
+12% vs 2023
EBITDA margin
1.3%
+145% vs 2023
Equity ratio
76.9%
Financial strength
Net profit 2024
NOK 28K
+153% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
0M
2020
0M
0%
2021
1M
+100%
2022
0M
-100%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 4M
+12%
EBITDA
NOK 53K
+145%
Net profit
NOK 28K
+153%
Total assets
NOK 1,1M
+3%
Equity
NOK 857K
+3%
Employees
2
—
Company information
Legal name
MILEX NORGE AS
Org number
979399030
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
25. oktober 1997
Share capital
—
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Contact
Address
Skjelavikvegen 73, 5515 Haugesund
Website
www.milex.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Haugesund
All Norway companies
Revenue
NOK millions
0M
1M
2M
3M
5M
2M
2020
3M
2021
3M
2022
4M
2023
4M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
1M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
2 351
2 698
3 210
3 560
4 001
Staff expenses
−321
−331
−342
−332
−331
EBITDA
110
469
574
−117
53
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
110
469
574
−117
53
Net financials
5
−0
−58
65
−25
Profit before tax
115
469
516
−53
28
Tax
25
103
114
−0
−0
Net profit
90
366
402
−53
28
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
645
769
1 240
1 086
1 114
Equity
413
479
882
829
857
Long-term debt
0
0
0
0
0
Short-term debt
232
290
359
258
257
Total debt
232
290
359
258
257
Financial ratios
5-year trend
EBITDA margin
1.3%
This company
15.8%
Market median
-92% vs market
2020
2024
Equity ratio
76.9%
This company
38.2%
Market median
+101% vs market
2020
2024
Return on equity
3.3%
This company
18.4%
Market median
-82% vs market
2020
2024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
2020
2024
Asset turnover
3.59×
This company
1.12×
Market median
+221% vs market
2020
2024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
BC
Bjarne Christian Sollie-Eriksen
Chairman
2020
GT
Gerd Thuen Eriksen
Board of Directors
2020
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Bajani Holding As
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Bajani Holding As
MILEX NORGE AS
(this company)
Board network connections
Board members of MILEX NORGE AS also hold positions in
0
other companies.
Person
Role here
Other companies
Bjarne Christian Sollie-Eriksen
Chairman
0 companies
Gerd Thuen Eriksen
Board of Directors
0 companies